Annual Gross Margin
59.51%
+5.36%+9.90%
01 December 2023
Summary:
Sinovac Biotech annual gross profit margin is currently 59.51%, with the most recent change of +5.36% (+9.90%) on 01 December 2023. During the last 3 years, it has fallen by -27.33% (-31.47%). SVA annual gross margin is now -37.01% below its all-time high of 94.47%, reached on 31 December 2021.SVA Gross Margin Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Gross Margin
N/A
01 June 2024
Summary:
Sinovac Biotech quarterly gross profit margin is not available.SVA Quarterly Gross Margin Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
SVA Gross Margin Performance
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | - | - |
3 y3 years | -31.5% | - |
5 y5 years | -33.3% | - |
SVA Gross Margin High & Low
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3 years | -37.0% | +9.9% | ||
5 y | 5 years | -37.0% | +9.9% | ||
alltime | all time | -37.0% | +1166.5% |
Sinovac Biotech Gross Margin History
Date | Annual | Quarterly |
---|---|---|
Dec 2023 | 59.51%(+9.9%) | - |
Dec 2022 | 54.15%(-42.7%) | - |
Dec 2021 | 94.47%(+8.8%) | - |
Dec 2020 | 86.84%(+0.0%) | 86.71%(-1.2%) |
Sept 2020 | - | 87.78%(+2.6%) |
June 2020 | - | 85.55%(-1.8%) |
Mar 2020 | - | 87.13%(+2.6%) |
Dec 2019 | 86.80%(-2.7%) | 84.90%(+1.2%) |
Sept 2019 | - | 83.92%(-7.3%) |
June 2019 | - | 90.49%(+0.9%) |
Mar 2019 | - | 89.66%(+2.6%) |
Dec 2018 | 89.23%(+1.0%) | 87.35%(-4.4%) |
Sept 2018 | - | 91.37%(+6.3%) |
June 2018 | - | 85.97%(-8.6%) |
Mar 2018 | - | 94.11%(+28.1%) |
Dec 2017 | 88.39%(+28.0%) | - |
Dec 2016 | 69.08%(-5.0%) | 73.46%(-8.3%) |
Sept 2016 | - | 80.15%(-146.8%) |
June 2016 | - | -171.39%(-396.7%) |
Mar 2016 | - | 57.77%(-15.5%) |
Dec 2015 | 72.69%(-3.6%) | 68.33%(+2.1%) |
Sept 2015 | - | 66.90%(-18.7%) |
June 2015 | - | 82.25%(+9.8%) |
Mar 2015 | - | 74.93%(-5.4%) |
Dec 2014 | 75.41%(+5.6%) | 79.22%(+11.7%) |
Sept 2014 | - | 70.92%(-5.4%) |
June 2014 | - | 74.98%(-1.1%) |
Mar 2014 | - | 75.80%(+5.0%) |
Dec 2013 | 71.43%(+16.7%) | 72.16%(+9.1%) |
Sept 2013 | - | 66.14%(-15.1%) |
June 2013 | - | 77.88%(+10.9%) |
Mar 2013 | - | 70.23%(+26.3%) |
Dec 2012 | 61.19% | 55.60%(+5.7%) |
Sept 2012 | - | 52.61%(-38.3%) |
Date | Annual | Quarterly |
---|---|---|
June 2012 | - | 85.31%(+37.1%) |
Mar 2012 | - | 62.24%(+0.4%) |
Dec 2011 | 62.83%(+25.8%) | 62.01%(+9.1%) |
Sept 2011 | - | 56.83%(-17.4%) |
June 2011 | - | 68.84%(+5.3%) |
Mar 2011 | - | 65.40%(-416.9%) |
Dec 2010 | 49.95%(-34.4%) | -20.64%(-130.2%) |
Sept 2010 | - | 68.26%(-17.5%) |
June 2010 | - | 82.70%(+3.2%) |
Mar 2010 | - | 80.12%(+15.6%) |
Dec 2009 | 76.17%(-3.1%) | 69.28%(-16.2%) |
Sept 2009 | - | 82.68%(+1.8%) |
June 2009 | - | 81.20%(+4.2%) |
Mar 2009 | - | 77.95%(+24.4%) |
Dec 2008 | 78.63%(-2.5%) | 62.66%(-22.7%) |
Sept 2008 | - | 81.05%(-3.7%) |
June 2008 | - | 84.18%(-4.5%) |
Mar 2008 | - | 88.18%(+29.1%) |
Dec 2007 | 80.61%(+11.3%) | 68.32%(-19.3%) |
Sept 2007 | - | 84.71%(-1.2%) |
June 2007 | - | 85.70%(+7.2%) |
Dec 2006 | 72.44%(-0.4%) | - |
June 2006 | - | 79.91%(+10.0%) |
Dec 2005 | 72.74%(+4.0%) | 72.62%(0.0%) |
Sept 2005 | - | 72.62%(-0.5%) |
June 2005 | - | 73.02%(-4.2%) |
Dec 2004 | 69.97%(+13.3%) | 76.22%(+23.6%) |
Sept 2004 | - | 61.68%(-7.6%) |
June 2004 | - | 66.75%(-20.5%) |
Dec 2003 | 61.75%(+35.1%) | 83.97%(+206.7%) |
Sept 2003 | - | 27.38% |
Apr 2002 | 45.69%(+44.5%) | - |
Apr 2001 | 31.62%(-666.7%) | - |
Apr 2000 | -5.58% | - |
FAQ
- What is Sinovac Biotech annual gross profit margin?
- What is the all time high annual gross margin for Sinovac Biotech?
- What is the all time high quarterly gross margin for Sinovac Biotech?
What is Sinovac Biotech annual gross profit margin?
The current annual gross margin of SVA is 59.51%
What is the all time high annual gross margin for Sinovac Biotech?
Sinovac Biotech all-time high annual gross profit margin is 94.47%
What is the all time high quarterly gross margin for Sinovac Biotech?
Sinovac Biotech all-time high quarterly gross profit margin is 94.11%